Quote | Mainz Biomed B.V. (NASDAQ:MYNZ)
Last: | $0.7842 |
---|---|
Change Percent: | -2.72% |
Open: | $0.7601 |
Close: | $0.7842 |
High: | $0.8 |
Low: | $0.7 |
Volume: | 308,149 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
News | Mainz Biomed B.V. (NASDAQ:MYNZ)
BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D....
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArl...
Message Board Posts | Mainz Biomed B.V. (NASDAQ:MYNZ)
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | budfoxfun | investorshub | 04/27/2023 10:08:15 PM |
$MYNZ The now | cuggegrosse | investorshub | 04/27/2023 6:07:40 PM |
Thoughts on where this is headed? | Mrogers23 | investorshub | 04/27/2023 5:51:00 PM |
That cat bounced. Poped back over $4. | BooDog | investorshub | 04/27/2023 2:31:33 PM |
$MYNZ The now last up | BlazingStocks | investorshub | 04/27/2023 11:42:39 AM |
News, Short Squeeze, Breakout and More Instantly...
Mainz Biomed B.V. Company Name:
MYNZ Stock Symbol:
NASDAQ Market:
BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D....
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArl...
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) a...